This sounds a little extreme and something out of the book 1984!
As cases of hepatitis C boom across Colorado and doctors work furiously to guide patients from diagnosis to cure, there is one challenge that can be surprisingly difficult. Patients have to take their medicine.
So now, as part of three ambitious studies that could radically improve the detection of hepatitis C and care for people who have it, researchers at Denver Health are trying something futuristic: a pill that will tell doctors whether a patient took it.
The pill, basically a gelcap, contains hepatitis C medicine and a microscopically small sensor that, when it hits the stomach, beams out a signal. (The sensor then dissolves harmlessly.) The signal gets picked up by a patch worn on the skin, and that patch syncs with an iPad that uses mobile networks to upload the information to the internet, where a doctor can see which patients haven’t taken their pills that day and give them a call to remind them.